GlaxoSmithKline (GSK) and Medicago have announced a collaboration for the development and evaluation of a COVID-19 vaccine candidate. The collaboration was revealed in a July 7, 2020 press release.
The candidate vaccine will combine Medicago s recombinant coronavirus virus-like particles (
